Search

Xencor Inc

Closed

SectorHealthcare

23.71 -0.55

Overview

Share price change

24h

Current

Min

23.6

Max

23.9

Key metrics

By Trading Economics

Income

107M

-22M

Sales

47M

51M

EPS

-0.29

Profit margin

-42.422

Employees

260

EBITDA

109M

-12M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+36.79% upside

Dividends

By Acuity

Next Earnings

3 lis 2026

Market Stats

By TradingEconomics

Market Cap

423M

1.9B

Previous open

24.26

Previous close

23.71

News Sentiment

By Acuity

43%

57%

86 / 339 Ranking in Healthcare

Xencor Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 wrz 2026, 19:46 UTC

Xencor Inc shares fell sharply, continuing a downward trend since Wednesday and remaining significantly below its 20-day moving average amid broader market weakness.

23 wrz 2026, 20:07 UTC

Correlated Moves

Xencor Inc shares fell sharply, reflecting a broader decline linked to significant losses in the Direxion Daily S&P Biotech Bull 3X ETF.

22 wrz 2026, 19:45 UTC

Xencor Inc is modestly higher, continuing positive momentum after four consecutive sessions of gains, despite remaining below its 20-day moving average.

21 wrz 2026, 20:31 UTC

Xencor Inc. has risen in after-market trading, recovering from an initial dip and reaching a peak notably higher than Monday's close.

17 wrz 2026, 20:07 UTC

Correlated Moves

Xencor Inc is advancing, likely supported by a rally in the biotechnology sector following positive Phase 3 results for Moderna's cancer vaccine.

16 wrz 2026, 19:16 UTC

Xencor Inc is trading roughly flat, having fluctuated within a typical range but remains significantly below its 20-day moving average.

15 wrz 2026, 23:16 UTC

Shares of Xencor Inc. are lower in after-market hours amid broader market pressures and rising yields on the ten-year Treasury note.

10 wrz 2026, 20:07 UTC

Xencor Inc's shares are lower today, continuing a trend of three consecutive daily declines and trading below the 20-day moving average.

8 wrz 2026, 20:07 UTC

Xencor Inc shares are trading lower today, following a notable early decline and remaining below their 20-day moving average. No specific news was identified.

4 wrz 2026, 20:07 UTC

Xencor Inc shares are higher, recovering from earlier losses amid broader market selling pressure following a strong jobs report. No specific news was identified.

3 wrz 2026, 22:15 UTC

News

Shares lower in after-market trading after JP Morgan's rating.

2 wrz 2026, 20:08 UTC

Xencor Inc shares are lower today, reversing from an early gain amid a weaker-than-expected ADP employment report affecting investor sentiment on interest rates.

1 wrz 2026, 23:01 UTC

Xencor Inc shares are lower in after-market hours, with no specific news identified. This decline occurs amid broader market concerns over economic growth data.

31 sie 2026, 20:03 UTC

Xencor Inc shares are higher today, supported by strong trading volume. The stock is above its 20-day moving average and near its one-month range high.

28 sie 2026, 20:02 UTC

Xencor Inc shares are lower today, breaking a trend of higher closes. The decline occurs amid rising U.S. Treasury yields and high trading volume.

27 sie 2026, 20:07 UTC

Xencor Inc shares are higher today, recovering from an early dip. The stock is trading well above its 20-day moving average.

26 sie 2026, 23:01 UTC

Xencor Inc shares are lower in after-market trading amid overall market declines. No specific news was identified to explain the stock's movement.

25 sie 2026, 19:36 UTC

Xencor Inc shares are higher, supported by declining crude oil prices and lower Treasury yields. The stock remains above its 20-day moving average.

24 sie 2026, 19:46 UTC

Xencor Inc's shares are higher Monday, rebounding from an earlier low amid rising oil prices and geopolitical tensions, despite no specific company news.

21 sie 2026, 21:41 UTC

Xencor Inc shares are higher in after-market trading, following a recent trend that shows a 44% increase over the past month.

20 sie 2026, 19:56 UTC

Correlated Moves

Xencor Inc shares declined during Thursday's session amid broader sector weakness, influenced by negative sentiment following Walmart's disappointing earnings report.

19 sie 2026, 20:03 UTC

Xencor Inc shares are higher during Wednesday's session, driven by strong market performance and high trading volume. No specific news was identified to explain the move.

18 sie 2026, 20:03 UTC

Xencor Inc shares are trading higher today, supported by strong upward momentum and unusually high market volume. No specific news was identified for the movement.

17 sie 2026, 19:26 UTC

Social Media

Xencor Inc shares are lower despite increased institutional interest, including Johnson & Johnson's $12 million acquisition of 748,062 shares.

14 sie 2026, 19:16 UTC

Shares of Xencor Inc. are modestly higher amid cautious broader market sentiment following a decline in U.S. retail sales for July.

13 sie 2026, 19:21 UTC

Xencor Inc shares are lower today, with no specific news driving the decline. High trading volume suggests increased activity amid routine fluctuations.

12 sie 2026, 19:56 UTC

Social Media

Xencor Inc shares are higher, supported by social media discussions valuing the company at $1.3 billion based on its ENPP3 asset potential.

11 sie 2026, 19:26 UTC

Xencor Inc shares are advancing, continuing a four-session trend. Investors are focused on upcoming inflation reports that may influence market sentiment.

10 sie 2026, 19:31 UTC

News

Xencor Inc shares are higher today, buoyed by increased institutional investments from Dimensional Fund Advisors and BVF Inc. IL.

7 sie 2026, 23:16 UTC

Xencor Inc shares are higher in after-market trading, supported by decreased interest rate hike expectations following a Labor Department report on non-farm payrolls.

Peer Comparison

Price change

Xencor Inc Forecast

Price Target

By TipRanks

36.79% upside

12 Months Forecast

Average 32.556 USD  36.79%

High 46 USD

Low 20 USD

Based on 12 Wall Street analysts offering 12 month price targets forXencor Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

10

Buy

2

Hold

0

Sell

Sentiment

By Acuity

86 / 339 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Xencor Inc

Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design XmAb technologies and develop candidates with properties. Its antibody design is focused on the segment of antibodies that interact with target antigens. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Vibecotamab, Tidutamab, XmAb841, XmAb104, XmAb306, XmAb104, XmAb564 and XmAb698.